These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 30655616)
1. HPV, tumour metabolism and novel target identification in head and neck squamous cell carcinoma. Fleming JC; Woo J; Moutasim K; Mellone M; Frampton SJ; Mead A; Ahmed W; Wood O; Robinson H; Ward M; Woelk CH; Ottensmeier CH; King E; Kim D; Blaydes JP; Thomas GJ Br J Cancer; 2019 Feb; 120(3):356-367. PubMed ID: 30655616 [TBL] [Abstract][Full Text] [Related]
2. Association of lnc-IL17RA-11 with increased radiation sensitivity and improved prognosis of HPV-positive HNSCC. Song L; Xie H; Tong F; Yan B; Zhang S; Fu E; Jing Q; Wei L J Cell Biochem; 2019 Oct; 120(10):17438-17448. PubMed ID: 31119798 [TBL] [Abstract][Full Text] [Related]
3. Clinical implications of activation of the LIMD1-VHL-HIF1α pathway during head-&-neck squamous cell carcinoma development. Mukhopadhyay D; Chakraborty B; Sarkar S; Alam N; Panda CK Indian J Med Res; 2024 May; 159(5):479-493. PubMed ID: 39382421 [TBL] [Abstract][Full Text] [Related]
4. Integrin alpha 6 as a stemness driver is a novel promising target for HPV (+) head and neck squamous cell carcinoma. An JS; Moon JH; Kim C; No JK; Eun YG; Chang Lim Y Exp Cell Res; 2021 Oct; 407(2):112815. PubMed ID: 34496296 [TBL] [Abstract][Full Text] [Related]
5. Antitumour effects of metformin and curcumin in human papillomavirus positive and negative head and neck cancer cells. Lindsay C; Kostiuk M; Conrad D; O'Connell DA; Harris J; Seikaly H; Biron VL Mol Carcinog; 2019 Nov; 58(11):1946-1959. PubMed ID: 31338907 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of CDK4/CDK6 Enhances Radiosensitivity of HPV Negative Head and Neck Squamous Cell Carcinomas. Göttgens EL; Bussink J; Leszczynska KB; Peters H; Span PN; Hammond EM Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):548-558. PubMed ID: 31271827 [TBL] [Abstract][Full Text] [Related]
7. PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas. Riva G; Pecorari G; Biolatti M; Pautasso S; Lo Cigno I; Garzaro M; Dell'Oste V; Landolfo S Mol Biol Rep; 2019 Jun; 46(3):3333-3347. PubMed ID: 30980272 [TBL] [Abstract][Full Text] [Related]
8. SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck Squamous Cell Carcinoma. Hémon A; Louandre C; Lailler C; Godin C; Bottelin M; Morel V; François C; Galmiche A; Saidak Z Biochem Biophys Res Commun; 2020 Dec; 533(4):1083-1087. PubMed ID: 33019976 [TBL] [Abstract][Full Text] [Related]
9. Preferential activation of the hedgehog pathway by epigenetic modulations in HPV negative HNSCC identified with meta-pathway analysis. Fertig EJ; Markovic A; Danilova LV; Gaykalova DA; Cope L; Chung CH; Ochs MF; Califano JA PLoS One; 2013; 8(11):e78127. PubMed ID: 24223768 [TBL] [Abstract][Full Text] [Related]
10. Expression of human papillomavirus oncoproteins E6 and E7 inhibits invadopodia activity but promotes cell migration in HPV-positive head and neck squamous cell carcinoma cells. Kahue CN; Jerrell RJ; Parekh A Cancer Rep (Hoboken); 2018 Oct; 1(3):e1125. PubMed ID: 32721084 [TBL] [Abstract][Full Text] [Related]
11. Cigarette Smoke Induces Metabolic Reprogramming of the Tumor Stroma in Head and Neck Squamous Cell Carcinoma. Domingo-Vidal M; Whitaker-Menezes D; Martos-Rus C; Tassone P; Snyder CM; Tuluc M; Philp N; Curry J; Martinez-Outschoorn U Mol Cancer Res; 2019 Sep; 17(9):1893-1909. PubMed ID: 31239287 [TBL] [Abstract][Full Text] [Related]
12. Comparative Gene Expression Profiling of Tobacco-Associated HPV-Positive versus Negative Oral Squamous Carcinoma Cell Lines. Lepore S; Lettini G; Condelli V; Sisinni L; Piscazzi A; Simeon V; Zoppoli P; Pedicillo MC; Natalicchio MI; Pietrafesa M; Landriscina M Int J Med Sci; 2020; 17(1):112-124. PubMed ID: 31929745 [No Abstract] [Full Text] [Related]
14. EGFR overexpression increases radiotherapy response in HPV-positive head and neck cancer through inhibition of DNA damage repair and HPV E6 downregulation. Alsahafi EN; Thavaraj S; Sarvestani N; Novoplansky O; Elkabets M; Ayaz B; Tavassoli M; Legends MF Cancer Lett; 2021 Feb; 498():80-97. PubMed ID: 33137407 [TBL] [Abstract][Full Text] [Related]
15. 5-Hydroxymethylation highlights the heterogeneity in keratinization and cell junctions in head and neck cancers. Liu S; de Medeiros MC; Fernandez EM; Zarins KR; Cavalcante RG; Qin T; Wolf GT; Figueroa ME; D'Silva NJ; Rozek LS; Sartor MA Clin Epigenetics; 2020 Nov; 12(1):175. PubMed ID: 33203436 [TBL] [Abstract][Full Text] [Related]
16. Cao CH; Liu R; Lin XR; Luo JQ; Cao LJ; Zhang QJ; Lin SR; Geng L; Sun ZY; Ye SK; Yu ZY; Shi Y; Xia X Int J Biol Sci; 2021; 17(7):1744-1756. PubMed ID: 33994859 [TBL] [Abstract][Full Text] [Related]
17. Heterogeneous nuclear ribonucleoprotein K is overexpressed and contributes to radioresistance irrespective of HPV status in head and neck squamous cell carcinoma. Kähler J; Hafner S; Popp T; Hermann C; Rump A; Port M; Steinestel K; Eder S Int J Mol Med; 2020 Nov; 46(5):1733-1742. PubMed ID: 32901844 [TBL] [Abstract][Full Text] [Related]
18. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients. Li J; Tang LL; Ma J BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785 [TBL] [Abstract][Full Text] [Related]
20. CENPM upregulation by E5 oncoprotein of human papillomavirus promotes radiosensitivity in head and neck squamous cell carcinoma. Liu T; Ma L; Song L; Yan B; Zhang S; Wang B; Zuo N; Sun X; Deng Y; Ren Q; Li Y; Zhou J; Liu Q; Wei L Oral Oncol; 2022 Jun; 129():105858. PubMed ID: 35462155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]